A Medical Device Daily
Maquet Cardiovascular (Wayne, New Jersey) has signed a three-year contract with Novation (Irving, Texas) to provide all of its cardiopulmonary (perfusion) products to the members of VHA (Irving, Texas), University HealthSystem Consortium (UHC; Oak Brook, Illinois) and Provista (Irving, Texas).
The agreement becomes effective on Jan. 1, 2010 and runs through Dec. 31, 2012. Maquet Cardiovascular's cardiopulmonary products are used in on-pump cardiac surgery and include heart-lung machines, the Quadrox-i family of generators, the Rotaflow Centrifugal Pump, the MECC (Minimized Extracorporeal Circulation) System, the Plegiox Cardioplegia Heat Exchanger, standard or customized tubing packs and a full line of adult, pediatric and ECMO cannulae.
"This agreement represents an important milestone for Maquet Cardiovascular as it is our first GPO contract for cardiopulmonary products in the United States and underscores the value of our products to surgeons and perfusionists," said Raoul Quintero, president of Maquet Cardiovascular U.S. sales. "We are committed to supporting positive patient outcomes and are pleased that members will now have access to our full range of innovative perfusion products, as well as our surgical devices for beating heart cardiac surgery and our market-leading Vasoview Endoscopic Vessel Harvesting (EVH) Systems through two contracts we signed with Novation previously."
"Novation continues to provide members of VHA, UHC and Provista with the most advanced technology, best customer service and preferred pricing. We found that Maquet Cardiovascular's cardiopulmonary product portfolio met the requirements of our rigorous contracting review process," said Scott Crandall, Senior Director, Contract Services Cardiology at Novation. "We are pleased that this is the third agreement we have signed this year with Maquet Cardiovascular."
In other agreements/contracts news:
• Premier Purchasing Partners (Charlotte, North Carolina) reported new agreements for disposable non-sterile protective apparel have been awarded to AllCare (Bartlett, Illinois), Cardinal Health (Waukegan, Illinois) and Medline Industries (Mundelein, Illinois). Effective Dec. 1, 2009, the agreements are available to acute care and continuum of care members of the Premier healthcare alliance.
• BioMimetic Therapeutics (Franklin, Tennessee) has shipped its first order of Augment Bone Graft to its Canadian distributor, Joint Solutions Alliance (Burlington, Ontario). Joint Solutions is the exclusive distributor of BioMimetic's Augment Bone Graft product in Canada. BioMimetic will also use product specialists in the Canadian market to work collaboratively with the Joint Solutions Team. The product was recently approved by Health Canada for use as an alternative to autograft in foot and ankle fusion surgery. Augment is a completely synthetic grafting system for bone regeneration and is composed of a purified recombinant growth factor, recombinant human platelet derived growth factor and a synthetic calcium phosphate matrix, beta-tricalcium phosphate.